Determination of Vancomycin B and Vancomycin Impurities by Liquid Chromatography
https://doi.org/10.30895/1991-2919-2021-11-4-246-254
Abstract
The preferred test methods for control of product-related impurities in medicinal products are high-performance liquid chromatography (HPLC) with a fine sorbent, and ultra-performance liquid chromatography (UPLC), which allow for better chromatographic separation of active substances and related impurities, reduction of time costs, and saving of material resources. The aim of the study was to develop HPLC and UPLC test procedures and assess the chromatographic separation capacity and efficiency in order to improve determination of the main vancomycin component and related impurities. Materials and methods: vancomycin hydrochloride lyophilisate for oral solution and solution for injection, and vancomycin hydrochloride reference standard (USP RS) were used as test objects. Agilent 1290 Infinity liquid chromatography system, and Chromolith® Performance RP-18e, Kinetex C18, Nucleodur C18 Isis, Zorbax RRHD Eclipse Plus C18, and LiChrospher® RP-18 columns were used for the testing. Results: HPLC analysis using a Chromolith® column (100×4.6 mm) reduces the testing time by 10 minutes compared to the USP test procedure, and by 15 minutes compared to the British Pharmacopoeia procedure. The proposed test procedure requires less eluent and increases chromatographic separation efficiency. UPLC analysis using a Kinetex C18 column (50×4.6 mm, 2.6 μm) made it possible to reduce the testing time by two thirds compared to the British Pharmacopoeia procedure. The use of isocratic elution greatly simplified the testing. The testing time under the proposed chromatographic conditions was 10 minutes. Conclusions: the selected HPLC and UPLC test conditions made it possible to significantly reduce the time of testing, minimise the use of expensive reagents, and increase efficiency of chromatographic separation in the determination of vancomycin impurities and the main component Vancomycin B.
Keywords
About the Authors
S. I. KuleshovaRussian Federation
Svetlana I. Kuleshova, Cand. Sci. (Biol.)
8/2 Petrovsky Blvd, Moscow 127051
E. P. Simonova
Russian Federation
Elena P. Simonova
8/2 Petrovsky Blvd, Moscow 127051
O. N. Vysochanskaya
Russian Federation
Olga N. Vysochanskaya
8/2 Petrovsky Blvd, Moscow 127051
References
1. Javorska L, Kujovska Krcmova L, Solichova D, Solich P, Kaska M. Modern methods for vancomycin determination in biological fluids by methods based on high-performance liquid chromatography. J Sep Sci. 2016;39(1):6–20. https://doi.org/10.1002/jssc.201500600
2. Голубицкий ГБ, Куликов АЛ. UPLC vs. HPLC: Реальное ускорение. В кн.: Аналитическая хроматография и капиллярный электрофорез. Материалы Всероссийской конференции. Краснодар; 2013. С. 24. [Golubitsky GB, Kulikov AL. UPLC vs. HPLC: real acceleration. In: Analytical Chromatography and Capillary Electrophoresis. Materials of the All-Russian conference. Krasnodar; 2013. P. 24 (In Russ.)]
3. Magreault S, Leroux S, Touati J, Storme T, Jacqz-Aigrain E. UPLC/MS/MS assay for the simultaneous determination of seven antibiotics in human serum – application to pediatric studies. J Pharm Biomed Anal. 2019;174:256–62. https://doi.org/10.1016/j.jpba.2019.03.004
4. Levine DP. Vancomycin: a history. Clin Infect Dis. 2006;42(Suppl 1):S5–12. https://doi.org/10.1086/491709
5. Archer GL. Antimicrobial susceptibility and selection ore resistance among Staphylococcus epidermidis isolates from patients with infections of indwelling foreign devices. Antimicrob Agents Chemother. 1978;14(3):353–9. https://doi.org/10.1128/AAC.14.3.353
6. Блатун ЛА, Крутиков МГ, Гришина ИА, Бобровников АЕ, Алексеев АА, Светухин АМ, Яковлев ВП. Клинико-лабораторная оценка эффективности ванкомицина (эдицин) при лечении гнойных ран кожи и мягких тканей, ожоговых ран и инфекционных осложнений ожоговой болезни. Антибиотики и химиотерапия. 2000;45(2):22–7. [Blatun LA, Krutikov MG, Grishina IA, Bobrovnikov AE, Alekseev AA, Svetukhin AM, Yakovlev VP. Clinical and laboratory evaluation of vancomycin (Edicin®) efficacy in the treatment of purulent wounds of the skin and soft tissues, burn wounds and infectious complications of burn disease. Antibiotiki i khimioterapiya = Antibiotics and Chemotherapy. 2000;45(2):22–7 (In Russ.)]
7. Cao Yu, Yu J, Chen Yu, Zhang J, Wu X, Zhang Y, Li G. Development and validation of a new ultra-performance liquid chromatographic method for vancomycin assay in serum and its application to therapeutic drug monitoring. Ther Drug Monit. 2014;36(2):175–81. https://doi.org/10.1097/FTD.0b013e3182a458bc
8. Nirmala K, Ramesh Raju R. Determination of vancomycin by using RP-HPLC method in pharmaceutical preparations. Int J Res Ayurveda Pharm. 2013;4(1):116–9. https://doi.org/10.7897/2277-4343.04139
Supplementary files
Review
For citations:
Kuleshova S.I., Simonova E.P., Vysochanskaya O.N. Determination of Vancomycin B and Vancomycin Impurities by Liquid Chromatography. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2021;11(4):246-254. (In Russ.) https://doi.org/10.30895/1991-2919-2021-11-4-246-254